Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

95.41EUR
15 Aug 2014
Price Change (% chg)

€-2.28 (-2.33%)
Prev Close
€97.69
Open
€97.78
Day's High
€98.45
Day's Low
€95.03
Volume
2,510,992
Avg. Vol
2,161,894
52-wk High
€114.20
52-wk Low
€90.71

BAYGn.DE

Chart for BAYGn.DE

About

Bayer AG is a German holding company active in the field of health care, nutrition and high-tech materials. It has three subgroups: HealthCare, involved in the research, development and production of health products for people and animals, CropScience, engaged in the crop protection and non-agricultural pest control, and... (more)

Overall

Beta: 0.92
Market Cap (Mil.): €88,524.77
Shares Outstanding (Mil.): 826.95
Dividend: 2.10
Yield (%): 1.96

Financials

  BAYGn.DE Industry Sector
P/E (TTM): 24.84 33.49 34.41
EPS (TTM): 4.31 -- --
ROI: 9.08 18.10 17.37
ROE: 18.35 18.76 18.18
Search Stocks

Bayer says animal health unit large enough

FRANKFURT - Bayer sought to dampen expectations that any proceeds from a separate listing of its plastics unit would be used for takeover deals to bolster its animal health activities.

30 Oct 2014

Bayer says animal health unit large enough

FRANKFURT, Oct 30 - Bayer sought to dampen expectations that any proceeds from a separate listing of its plastics unit would be used for takeover deals to bolster its animal health activities.

30 Oct 2014

Bayer says eyeing more deals after bulking up consumer care

FRANKFURT - Bayer is eyeing further takeover deals after wrapping up the acquisition of Merck & Co. Inc.'s consumer health business, the German drugmaker's chief executive said on Thursday.

30 Oct 2014

Bayer says eyeing more deals after bulking up consumer care

FRANKFURT, Oct 30 - Bayer is eyeing further takeover deals after wrapping up the acquisition of Merck & Co. Inc.'s consumer health business, the German drugmaker's chief executive said on Thursday.

30 Oct 2014

French stocks lead Europe higher on positive company results

* Germany's VW, Bayer also boosted by results but Linde plunges

30 Oct 2014

UPDATE 1-Bayer Q3 adj profit gains slightly on strong crop chemicals

* Shares gain 3.5 percent (Adds details on drug sales, analyst comment, shares)

30 Oct 2014

European Factors to Watch-Results to help euro zone shares edge up

LONDON, Oct 30 - European shares were set to edge higher on Thursday, helped by upbeat corporate updates from companies including drugmaker Bayer and car maker Renault.

30 Oct 2014

Bayer Q3 adj profit gains slightly on strong crop chemicals

FRANKFURT, Oct 30 - Germany's largest drugmaker Bayer said underlying core earnings advanced by 1.4 percent, slightly surpassing expectations, on strong sales at its pesticides unit.

30 Oct 2014

BRIEF-Bayer buys some DuPont crop protection assets

* Acquires certain DuPont Crop Protection Land Management business assets

29 Oct 2014

Private equity eyes $13 billion Bayer plastics business: sources

FRANKFURT/LONDON - Private equity firms are circling Bayer's 10 billion-euro ($12.7 billion) plastics business, hoping to divert the German drugmaker from its plan to list the division, two people familiar with the matter said on Wednesday.

22 Oct 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Sadif Analytics Prime
$10.00
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks